Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
Abstract Background The efficacy and safety of golimumab in elderly patients with renal dysfunction are not well evaluated due to the exclusion criteria of clinical trials. Objective To assess the persistence and safety of golimumab in elderly rheumatoid arthritis patients with renal dysfunction. Pa...
Main Authors: | Seiji Yokoyama, Yutaka Ishii, Junya Masuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2022-11-01
|
Series: | Drugs - Real World Outcomes |
Online Access: | https://doi.org/10.1007/s40801-022-00338-y |
Similar Items
-
A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
by: Masahiko Miyashiro, et al.
Published: (2023-02-01) -
THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01) -
Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
by: Taylor, P, et al.
Published: (2011) -
GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Wordsworth, P, et al.
Published: (2009) -
The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)